| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $339.4M | +3.9% |
| Cost of Revenue | $175.9M | +2.1% |
| R&D Expense | $37.2M | +20.4% |
| SG&A Expense | $76.2M | +35.5% |
| Operating Income | -$42.6M | -287.0% |
| Interest Expense | $12.5M | +98.1% |
| Pre-tax Income | -$54.4M | -400.8% |
| Income Tax | -$8.6M | -488.0% |
| Net Income | -$45.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -44.6% |
| Accounts Receivable | $59.7M | +16.4% |
| Inventory | $475K | -39.4% |
| Current Assets | $111.5M | +49.5% |
| Total Assets | $434.4M | +0.8% |
| Current Liabilities | $48.2M | +8.5% |
| Long-term Debt | $198.4M | +42.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.1M | -96.7% |
| Capital Expenditures | $346K | +28.1% |
| Investing Cash Flow | -$60.1M | +4.2% |
| Financing Cash Flow | $55.9M | +116.2% |
| Free Cash Flow | $713K | -97.8% |
| -388.6% |
| EPS (Basic) | -$3.15 | -391.7% |
| EPS (Diluted) | -$3.15 | -391.7% |
| Total Liabilities |
| $247.8M |
| +24.4% |
| Stockholders' Equity | $186.6M | -19.5% |